Non-bacterial thrombotic endocarditis historical perspective: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 13: Line 13:
*In 1936, The name non-bacterial thrombotic endocarditis was coined by Gross and Friedberg. <ref> GROSS L, FRIEDBERG CK. NONBACTERIAL THROMBOTIC ENDOCARDITIS: CLASSIFICATION AND GENERAL DESCRIPTION. Arch Intern Med (Chic). 1936;58(4):620–640. doi:10.1001/archinte.1936.00170140045004 </ref>. They postulated that the attachment of [[fibrin]] to [[cardiac valves]] is the cause of non-bacterial thrombotic endocarditis.
*In 1936, The name non-bacterial thrombotic endocarditis was coined by Gross and Friedberg. <ref> GROSS L, FRIEDBERG CK. NONBACTERIAL THROMBOTIC ENDOCARDITIS: CLASSIFICATION AND GENERAL DESCRIPTION. Arch Intern Med (Chic). 1936;58(4):620–640. doi:10.1001/archinte.1936.00170140045004 </ref>. They postulated that the attachment of [[fibrin]] to [[cardiac valves]] is the cause of non-bacterial thrombotic endocarditis.
*In recent years it has been suggested that NBTE is a [[hypercoagulable state]] caused by a [[malignancy]] that leads to a surge in [[tumor necrosis factor]] and [[interleukin-1]], resulting in the formation of [[thrombi]].<ref> Schlittler LA, Dallagasperina VW, Schavinski C, Baggio AP, Lazaretti NS, Villaroel RU. Marantic endocarditis and adenocarcinoma of unknown primary site. Arq Bras Cardiol. 2011;96(4):e73–5 </ref>    <br />
*In recent years it has been suggested that NBTE is a [[hypercoagulable state]] caused by a [[malignancy]] that leads to a surge in [[tumor necrosis factor]] and [[interleukin-1]], resulting in the formation of [[thrombi]].<ref> Schlittler LA, Dallagasperina VW, Schavinski C, Baggio AP, Lazaretti NS, Villaroel RU. Marantic endocarditis and adenocarcinoma of unknown primary site. Arq Bras Cardiol. 2011;96(4):e73–5 </ref>    <br />
*More recently, apart from malignancies, NBTEs have been associated with infectious and autoimmune diseases and more recently, sepsis and burns.<ref name="pmid16244577">{{cite journal |vauthors=Wada H, Sase T, Yamaguchi M |title=Hypercoagulant states in malignant lymphoma |journal=Exp. Oncol. |volume=27 |issue=3 |pages=179–85 |date=September 2005 |pmid=16244577 |doi= |url=}}</ref><ref name="pmid3916476">{{cite journal |vauthors=Ferrans VJ, Rodríguez ER |title=Cardiovascular lesions in collagen-vascular diseases |journal=Heart Vessels Suppl |volume=1 |issue= |pages=256–61 |date=1985 |pmid=3916476 |doi=10.1007/BF02072405 |url=}}</ref><ref name="pmid998478">{{cite journal |vauthors=Deppisch LM, Fayemi AO |title=Non-bacterial thrombotic endocarditis: clinicopathologic correlations |journal=Am. Heart J. |volume=92 |issue=6 |pages=723–9 |date=December 1976 |pmid=998478 |doi=10.1016/s0002-8703(76)80008-7 |url=}}</ref>


===Landmark Events in the Development of Treatment Strategies===
===Landmark Events in the Development of Treatment Strategies===

Revision as of 17:57, 10 July 2020

non-bacterial thrombotic endocarditis

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating non-bacterial thrombotic endocarditis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X-ray

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Non-bacterial thrombotic endocarditis historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Non-bacterial thrombotic endocarditis historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Non-bacterial thrombotic endocarditis historical perspective

CDC on Non-bacterial thrombotic endocarditis historical perspective

Non-bacterial thrombotic endocarditis historical perspective in the news

Blogs on Non-bacterial thrombotic endocarditis historical perspective

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Non-bacterial thrombotic endocarditis historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aisha Adigun, B.Sc., M.D.[2]

Overview

Historical Perspective

Discovery

  • The association between thromboembotic events and malignancy was made by Armand Trousseau in the year 1865.[1]
  • Non-bacterial thrombotic endocarditis (NBTE) was first discovered by Zeigler,[2] in 1888 following his identification of vegetation in cardiac valves associated with inflammatory states.
  • In 1926, Dr. Benjamin Sacks and Dr. Emmanuel Libman[3] published cases of "valvular masses" that were examined clinically and during autopsies and found to be free of all microorganisms. These masses were initially named "indeterminate endocarditis".
  • In 1936, The name non-bacterial thrombotic endocarditis was coined by Gross and Friedberg. [4]. They postulated that the attachment of fibrin to cardiac valves is the cause of non-bacterial thrombotic endocarditis.
  • In recent years it has been suggested that NBTE is a hypercoagulable state caused by a malignancy that leads to a surge in tumor necrosis factor and interleukin-1, resulting in the formation of thrombi.[5]
  • More recently, apart from malignancies, NBTEs have been associated with infectious and autoimmune diseases and more recently, sepsis and burns.[6][7][8]

Landmark Events in the Development of Treatment Strategies

Impact on Cultural History

Famous Cases

The following are a few famous cases of [disease name]:

References

  1. Trousseau A. Clinique médicale de l’Hôtel-Dieu de Paris. Paris: Ballière; 1865
  2. Lopez JA, Ross RS, Fishbein MC, Siegel RJ (March 1987). "Nonbacterial thrombotic endocarditis: a review". Am. Heart J. 113 (3): 773–84. doi:10.1016/0002-8703(87)90719-8. PMID 3548296.
  3. E Ziegler - Ver Kong Inn Med, 1888 - ci.nii.ac.jp
  4. GROSS L, FRIEDBERG CK. NONBACTERIAL THROMBOTIC ENDOCARDITIS: CLASSIFICATION AND GENERAL DESCRIPTION. Arch Intern Med (Chic). 1936;58(4):620–640. doi:10.1001/archinte.1936.00170140045004
  5. Schlittler LA, Dallagasperina VW, Schavinski C, Baggio AP, Lazaretti NS, Villaroel RU. Marantic endocarditis and adenocarcinoma of unknown primary site. Arq Bras Cardiol. 2011;96(4):e73–5
  6. Wada H, Sase T, Yamaguchi M (September 2005). "Hypercoagulant states in malignant lymphoma". Exp. Oncol. 27 (3): 179–85. PMID 16244577.
  7. Ferrans VJ, Rodríguez ER (1985). "Cardiovascular lesions in collagen-vascular diseases". Heart Vessels Suppl. 1: 256–61. doi:10.1007/BF02072405. PMID 3916476.
  8. Deppisch LM, Fayemi AO (December 1976). "Non-bacterial thrombotic endocarditis: clinicopathologic correlations". Am. Heart J. 92 (6): 723–9. doi:10.1016/s0002-8703(76)80008-7. PMID 998478.

Template:WH Template:WS